Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Adam J. Bass, Jin Zhou et al.|Nature Genetics|2021Cited by 111
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survivalLeonie K. de Klerk, Adam J. Bass, Jérémy Augustin et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 30